We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
 

Latest News

Coronado Biosciences Appoints Karin Hehenberger, M.D., Ph.D. as Senior Vice President of Scientific Affairs
News   Dec 22, 2011

Dr. Hehenberger’s responsibilities will initially be focused on broadening the scope of proof of concept trials in various autoimmune diseases with Coronado’s lead product CNDO-201.

READ MORE

Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business for $435,000
News   Dec 22, 2011

The assets include more than 1,000 prospectively collected diagnostic samples from ovarian tumor studies, three biomarker-related pending U.S. patents, proprietary software and other intellectual property.

READ MORE

NIH Scientists Find a Potential New Avenue for Cancer Therapies
News   Dec 20, 2011

NIH publishes the data online in the Dec. 19 issue of The Journal of Clinical Investigation.

READ MORE

Scientists Join Stand Up to Cancer and Melanoma Research Alliance Dream Team
News   Dec 19, 2011

Three Van Andel Research Institute (VARI) and Michigan State University scientists join other researchers nationwide, tasked with a $6 million project to find therapies for patients with a deadly form of melanoma that has few treatment options.

READ MORE

New Patent Grant for GeneICE & VAL101 Update
News   Dec 15, 2011

ValiRx Plc is pleased to announce that GeneICE (or “Gene inactivation by chromatin engineering”), its proprietary gene-silencing technology, has recently received patent approval by the Canadian patent office.

READ MORE

Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results
News   Dec 15, 2011

The company announced clinical trial results of the Phase 1 study of TH-302 in patients with advanced leukemias conducted at MD Anderson's Cancer Center in Houston, Texas.

READ MORE

Celgene Announce Final Phase II Data Evaluating REVLIMID® and Rituximab
News   Dec 14, 2011

The study reported overall response rate of 66% in patients with relapsed or refractory chronic lymphocytic leukemia, with 12% of patients achieving complete response. After a median follow-up of 31 months, overall survival Was 75%.

READ MORE

Meta-Analysis Confirms Link Between Epigenetic Changes and Prostate Cancer
News   Dec 14, 2011

Detection of epigenetic changes could provide better diagnosis and disease management as MDxHealth’s Prostate ConfirmMDxTM test helps identify men with suspected prostate cancer, thus avoiding unnecessary repeat biopsies.

READ MORE

Endocyte Announces Results of Supplemental Analyses of PRECEDENT Trial
News   Dec 13, 2011

Analyses confirm greatest benefit in FR(++) population.

READ MORE

RSNA Research Scholar Grant Update: Gene Expression Profiling in Cancer Patients
News   Dec 13, 2011

Michael S. Gee, MD, PhD, Massachusetts General Hospital, Radiology, was the 2010 recipient of the two-year Carestream Health/RSNA Research Scholar Grant Award for his work on the characterisation of cancer cells.

READ MORE

 
Advertisement